GeneDx Holdings Corp. (WGS) — Capital Reinvestment Ratio
Latest as of September 2025:
0.39x
GeneDx Holdings Corp. (WGS) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow ($15.77 Million) in capital expenditures ($6.17 Million). See GeneDx Holdings Corp. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.39x
Capex / Operating Cash Flow
Operating Cash Flow
$15.77 Million
USD
Capital Expenditures
$6.17 Million
USD
Data as of
Sep 2025
Most recent filing
GeneDx Holdings Corp. Capital Reinvestment Ratio (2025–2025)
This chart tracks GeneDx Holdings Corp.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for GeneDx Holdings Corp. (2025–2025)
Year-by-year Capital Reinvestment Ratio for GeneDx Holdings Corp. from 2025 to 2025. For live market cap and broader valuation context, see WGS market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | $33.28 Million | $19.02 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow